The novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor AS605240 in autoimmune diabetes.
about
Phosphatidylinositol 3-Kinase γ is required for the development of experimental cerebral malaria.PI3Kγ Deficient NOD-Mice Are Protected from Diabetes by Restoring the Balance of Regulatory to Effector-T-Cells.Advances in the cellular immunological pathogenesis of type 1 diabetesSelective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies.Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ.Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infection.
P2860
The novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor AS605240 in autoimmune diabetes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The novel therapeutic effect o ...... 605240 in autoimmune diabetes.
@ast
The novel therapeutic effect o ...... 605240 in autoimmune diabetes.
@en
type
label
The novel therapeutic effect o ...... 605240 in autoimmune diabetes.
@ast
The novel therapeutic effect o ...... 605240 in autoimmune diabetes.
@en
prefLabel
The novel therapeutic effect o ...... 605240 in autoimmune diabetes.
@ast
The novel therapeutic effect o ...... 605240 in autoimmune diabetes.
@en
P2093
P2860
P356
P1433
P1476
The novel therapeutic effect o ...... 605240 in autoimmune diabetes.
@en
P2093
Alessandra Petrelli
Ayumi Takakura
Jamil Azzi
Marwan Mounayar
Najib El Haddad
Robert F Moore
Sunmi Yang
Thomas Ruckle
Wassim Elyaman
P2860
P304
P356
10.2337/DB11-0134
P407
P577
2012-03-08T00:00:00Z